A 100 Million Dollar Investment: MEI Pharma Ventures Into Litecoin
Cryptos are leaving the margins. They are settling into balance sheets. Bitcoin started the trend, Ethereum followed. Now, some altcoins are attracting the attention of companies. The latest to take this step: Litecoin. Biotech company MEI Pharma has made a strong move. $100 million injected into a treasury strategy exclusively based on this altcoin. A first in the pharmaceutical sector.
In Brief
- MEI Pharma becomes the first publicly traded biotech company to exclusively bet on Litecoin in its treasury.
- Charlie Lee, creator of Litecoin, joins the board of directors to oversee this unprecedented strategy.
- MEIP stock jumped 83%, while Litecoin gained 12% in parallel.
- Luxxfolio follows the movement, doubling its LTC reserves and betting on institutional adoption.
A Crypto Boldness Signed MEI Pharma
MEI Pharma didn’t just buy Litecoin (LTC). It built around it a new strategic foundation. This Nasdaq-listed company raised $100 million through a private investment in public equity (PIPE) transaction. Its goal? To make LTC its primary reserve asset. It is the first time a biopharmaceutical company has dared such a decision.
The event does not stop at the purchase. MEI also welcomed Charlie Lee, creator of Litecoin, to its board of directors. He did not mince his words :
This partnership with GSR and MEI Pharma finally brings Litecoin’s mission into an institutional framework.
With GSR, a leader in crypto markets, as a digital asset management advisor, MEI has equipped itself with a formidable duo. Charlie Lee, a recognized pioneer, embodies visionary leadership. GSR, on the other hand, pilots the strategy and manages risks. The result: a hybrid governance between biotech, traditional finance, and crypto.
LTC in Orbit, MEIP Boiling
The announcement quickly stirred up waves. Litecoin jumped more than 12%, temporarily reaching $108. Its transaction volume exploded. The Charlie Lee effect? Certainly. But also the institutional effect.
At the same time, MEIP stock climbed 83% in pre-market, reaching a peak of $9.39. The 29 million shares transaction at $3.42 each was completed, reflecting massive investor enthusiasm.
Luxxfolio Holdings, another listed player, was not left indifferent. Since March, the company has increased its Litecoin treasury by 151.6% per share, now holding a total of 20,084 LTC.
This confirms a trend: Litecoin is no longer confined to individual payments. It is embedding itself into corporate strategies. It becomes a treasury tool. It becomes a trusted asset.
Litecoin: The Quiet Alternative that Packs a Punch
Why did MEI bet on Litecoin and not on Ethereum or Bitcoin? The answer is twofold: efficiency and discretion.
Litecoin was designed to be fast, secure, and decentralized – and it is exciting to see these principles now embraced by a publicly traded company like MEI.
Charlie Lee, Source: Businesswire .
Meanwhile, Litecoin shows massive usage in payments . On BitPay, it sometimes even surpasses Bitcoin in transaction volume.
And beyond the technical narrative, the numbers speak:
- 12.5% increase in LTC within 24 hours after the announcement;
- 83% gain in pre-market for MEIP;
- 29.2 million shares sold at $3.42 each to finance the operation;
- 151% increase in Litecoin treasury for Luxxfolio;
- $100 million allocated exclusively to the purchase of LTC.
The message is clear: Litecoin is no longer a secondary coin. It is an investment tool, a response to volatility, a strategic alternative.
With this unprecedented investment, MEI Pharma is paving the way for a new era for altcoins in corporate finance. But Litecoin is not stopping there. It is now aiming for ETFs, as evidenced by the recently postponed SEC verdict on the Litecoin and Solana ETFs . While Bitcoin settles among tech giants, LTC explores new markets. One step at a time, the gray crypto makes its way to the light.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The script at the end of 2018: The Federal Reserve continued to raise interest rates, US stocks plunged 20% from the September highs, forcing the Federal Reserve to "pivot" in January.
Goldman Sachs' head of trading believes the current US stock market is repeating the scenario of late 2018, with monetary tightening and equity market pressure. The Goldman Sachs Financial Conditions Index has tightened by about 8 points in two weeks, reaching the highest level in a year. The selloff has broadened from tech stocks to defensive sectors. Gold and equities are declining simultaneously, possibly indicating investors are selling assets to raise cash, making gold a key indicator for observing liquidity stress.

Goldman Sachs Trader “Revisits the 2018 Playbook”: Still Clearly Remembers “On December 24th, Clients Asked Why the Market Dropped So Much—And I Had No Idea”
Brian Garrett pointed out that the current adjustment in the US stock market is similar to the sharp decline in Q4 2018: the S&P 500 has already experienced 42% of the corresponding drop, and the VIX is approaching its peak just before Christmas. If history repeats itself, the bottom of this cycle may appear in January next year. However, the credit market and Federal Reserve policy have yet to provide clear signals of a bottom.
Anthropic (ANT.US) nearly “broke issue price,” but Claude knocks on the doors of “the highest peak in mathematics”! 17 million lines of Lean code used to write a candidate proof for the Riemann Hypothesis
On November 20th, Eastern Time, on its second day of trading, Anthropic's intraday price dropped to a low of $83.05, just 5 cents above the offering price of $83, and finally closed at $88.91, a decline of 8.50%. On the same day, the company's mathematician Levant Alperg announced on his personal website that he and Claude had found a candidate proof for the Riemann hypothesis, which has puzzled the mathematics community for 167 years, and released about 17 million lines of Lean formalized code.

As US stocks plummet, the parent company of GTA 6 rises against the market! First-day sales hit a record $3.79 billion; Wall Street shifts focus to next-generation GTA Online.
According to Rentrak data, the global box office of "Grand Theft Auto VI" has also surpassed that of "Avengers: Endgame," the highest-grossing film of all time, which has a global box office of approximately $2.94 billion.

